Release date: 2015-10-30
"I don't know enough, then I can reflexively; I know how to be sleepy, and then I can be self-reliant." Gu Wen advised the world to constantly reflect on it, knowing the shortcomings and difficulties, and then working hard to improve themselves. Under the favorable policy environment of the current state vigorously advocating the development and application of domestic medical devices, what difficulties and key points does China's medical device industry face?
Distance between desire and reality
China Medical Equipment Association Meng Jianguo said that in recent years, China's medical device market has grown at an average annual rate of over 20%. In 2013, there were more than 15,000 medical device manufacturers in the country, and the sales revenue of enterprises above designated size reached 328.7 billion yuan. In general, China's medical device industry is developing rapidly, but in the field of high-end large-scale medical equipment, there is still a certain distance from abroad.
It is worth noting that the “Opinions on Promoting the Development of Health Service Industry†issued by the State Council in 2013 proposes that by 2020, a health service system covering the whole life cycle, rich in content and reasonable structure will be established, and a number of well-known brands will be built. With a virtuous circle of health service industry clusters, the total size of the health service industry has reached more than 8 trillion yuan.
Among these 8 trillion yuan, medical devices may account for about 1 trillion yuan. In other words, by then, the output value of medical equipment in China will quadruple on the basis of the existing more than 200 billion yuan. Under this development situation, how to reshape the structure, strengthen cooperation, and achieve a win-win situation is an issue that needs to be studied.
Associate Professor Jiang Haihong of Shanghai Health Medical College analyzed that China has established many incentive mechanisms to promote the use of domestic medical devices. The trend of the policy is good, but the reality is still far from the policy aspiration. It should be noted that in the past two years, many medical equipment with low technical content have been localized, but the localization of high-end medical equipment is limited, and many core intellectual property technologies are in the hands of foreign companies. Under the guidance and support of the government and financial funds, it is estimated that public hospitals have little problem in promoting the use of domestically produced equipment, but private hospitals will not purchase domestically produced medical equipment. This means that there is still a long way to go before the promotion and use of domestic medical devices in some hospitals.
Insufficient key technologies
Among the several favorable policies and measures, the selection of excellent domestic medical equipment launched since 2013 has received wide attention in the industry. It is understood that in the past two years, the selection of ultrasound equipment, automatic biochemical analyzers, CT machines, magnetic resonance instruments, etc., which have a wide coverage, large dosage, a certain market share, and a significant effect on reducing medical costs, have been carried out. At the bottom of the survey and selection, two batches of excellent product catalogues have been published so far. In the selection criteria, equipment technical parameters accounted for 60%, corporate situation accounted for 20%, and expert evaluation accounted for 20%. By selecting the opinions of the users, the appraisers examined the funds and R&D capabilities of the company and found some common problems.
To sum up, the process and materials are two major problems that plague the industry. Without possession of key technologies, it is not a domestic medical device with independent intellectual property rights. Meng Jianguo told reporters that the selection work found that the ball tubes used in domestic CT machines are mostly imported components; domestic DR flat panel detectors have fewer manufacturers and technologies to be improved; domestic ultrasonic equipment enterprises do not need to be in more than 64 channels. Achieve technological breakthroughs; the precision and basic material level of the automatic biochemical analyzer manipulator needs to be further improved.
The development of medical devices requires close integration between hospitals and enterprises. However, many R&D personnel are only designing in the laboratory. The R&D personnel are not very familiar with the products that the hospital urgently needs. The practice of foreign companies is to build a research and development center around the hospital, often to the hospital to understand which products need to be developed or improved. At present, China urgently needs to establish a medical device demonstration application base to promote the linkage between enterprises and hospitals.
Medical equipment to be developed
China Medical Equipment Association survey found that China's current medical device innovation work needs to focus on 3.0 Tesla (T) superconducting magnetic resonance, 32-row CT, 64-channel ultrasound, high-throughput testing equipment, bedside testing (POCT) System, integrated pipeline inspection and analysis system, non-invasive ventilator and other fields.
In China's medical imaging equipment market, the future coverage of magnetic resonance products should be 1.5T and 3.0T superconducting magnetic resonance systems, the current domestic 3.0T magnetic resonance system still needs to be broken; in addition, Chinese enterprises already have 16 rows of CT machines Production capacity, but the 32-row CT machine is doing less, and the production technology of the 64-row CT machine is still monopolized by foreign companies.
It is particularly noteworthy that the selection of personnel did not find domestic non-invasive ventilators in the market. At present, Chinese enterprises only produce invasive ventilators. Because the use of invasive equipment requires a stoma on the patient, the level of operation of the doctor is very high, thus limiting the promotion of the invasive ventilator in small hospitals. In the future, almost all hospitals should be equipped with non-invasive ventilators. The proportion of non-invasive ventilators and invasive ventilators in the hospital should be 51, so domestic companies need to fill this gap.
In addition, in China's dialysis equipment market, the import dialysis machine accounted for more than 80%. Although the domestic dialysis machine is cheap, but because the supporting supplies can not keep up, it is difficult to open the market or encounter problems in clinical use.
According to experts' analysis, rehabilitation equipment and digital medical equipment are also the development directions that China's medical equipment industry should focus on. Cardiovascular diseases, diabetes, tumors and other chronic diseases are the focus of disease prevention and control in China. However, at present, there are very few domestically produced equipments suitable for the rehabilitation of chronic neurological function in the domestic market. Some enterprises have done some equipment with reference to imported equipment, such as cats and tigers. However, due to lack of big data support and follow-up scientific guidance, patients' rehabilitation The effect is affected.
Source: China Medical News
Carbomer is an acrylic resin obtained by cross-linking pentaerythritol with acrylic acid. It is a very important rheological regulator. After neutralization, carbomer is an excellent gel matrix, which has important applications such as thickening suspension. According to the dry product calculation, including carboxylic acid group (-cooh) should be 56.0 % ~ 68.0%.
Common carbopol series include: Carbopol 940, 941, 934, 1342, 980, ETD 2020, AQUA sf-1, Ultrez 21, Ultrez 20, etc.
Carbomer,Carbopol,Carbopol 940, Carbomer 940, Carbomer 980, acrylic acid
Xi'an Gawen Biotechnology Co., Ltd , https://www.ahualyn-bios.com